Allele-specific silencing therapy for Dynamin 2-related dominant centronuclear myopathy.

about

Centronuclear myopathies under attack: A plethora of therapeutic targets

P2860

Q58713722-32C16679-BD06-4987-80D9-DC293DCAA30E

P2860

Allele-specific silencing therapy for Dynamin 2-related dominant centronuclear myopathy.

Item

http://www.wikidata.org/entity/Q47778748

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Allele-specific silencing therapy for Dynamin 2-related dominant centronuclear myopathy.

@en

Allele-specific silencing therapy for Dynamin 2-related dominant centronuclear myopathy.

@nl

type

Item

label

Allele-specific silencing therapy for Dynamin 2-related dominant centronuclear myopathy.

@en

Allele-specific silencing therapy for Dynamin 2-related dominant centronuclear myopathy.

@nl

prefLabel

Allele-specific silencing therapy for Dynamin 2-related dominant centronuclear myopathy.

@en

Allele-specific silencing therapy for Dynamin 2-related dominant centronuclear myopathy.

@nl

P1476

Allele-specific silencing therapy for Dynamin 2-related dominant centronuclear myopathy.

@en

P2093

Arnaud Ferry

http://www.w3.org/2001/XMLSchema#string

Aymen Rabai

http://www.w3.org/2001/XMLSchema#string

Bernard Prudhon

http://www.w3.org/2001/XMLSchema#string

Cécile Peccate

http://www.w3.org/2001/XMLSchema#string

Jocelyn Laporte

http://www.w3.org/2001/XMLSchema#string

Kamel Mamchaoui

http://www.w3.org/2001/XMLSchema#string

Laura Julien

http://www.w3.org/2001/XMLSchema#string

Maud Beuvin

http://www.w3.org/2001/XMLSchema#string

P2860

Dynamin GTPase regulation is altered by PH domain mutations found in centronuclear myopathy patients

Allele-specific silencing of mutant Myh6 transcripts in mice suppresses hypertrophic cardiomyopathy

Silencing mutant ataxin-3 rescues motor deficits and neuropathology in Machado-Joseph disease transgenic mice

Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease

Mutations in dynamin 2 cause dominant centronuclear myopathy

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

Small RNAs with imperfect match to endogenous mRNA repress translation. Implications for off-target activity of small inhibitory RNA in mammalian cells.

Mutation spectrum in the large GTPase dynamin 2, and genotype-phenotype correlation in autosomal dominant centronuclear myopathy.

Allele-specific RNAi mitigates phenotypic progression in a transgenic model of Alzheimer's disease.

Coordinated actions of actin and BAR proteins upstream of dynamin at endocytic clathrin-coated pits

P304

239-253

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.15252/EMMM.201707988

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pascale Guicheney

Stéphane Vassilopoulos

Delphine Trochet

Stéphanie Lorain

Sofia Benkhelifa-Ziyyat

Marc Bitoun

P577

2017-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29246969

http://www.w3.org/2001/XMLSchema#string

P932

5801507

http://www.w3.org/2001/XMLSchema#string

Allele-specific silencing therapy for Dynamin 2-related dominant centronuclear myopathy.

about

P2860

P2860

Allele-specific silencing therapy for Dynamin 2-related dominant centronuclear myopathy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932